Search research articles
Contact Us
Filters
Showing results (111-120 of 227) with videos related to
Page
of 23
Sort By:
Journal of the American Heart Association
|
July 24, 2018
Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial
Gilles R Dagenais, Hyejung Jung, Eva Lonn, et al.
Journal of the American College of Cardiology
|
March 25, 2014
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes
Elaine M Hylek, Claes Held, John H Alexander, et al.
European Heart Journal
|
February 28, 2016
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
Ziad Hijazi, Johan Lindbäck, John H Alexander, et al.
Journal of the American Heart Association
|
October 26, 2017
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
Claes Held, Harvey D White, Ralph A H Stewart, et al.
American Heart Journal
|
April 30, 2017
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome
Neha J Pagidipati, Connie N Hess, Robert M Clare, et al.
Journal of the American Heart Association
|
February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
Tymon Pol, Claes Held, Johan Westerbergh, et al.
Circulation
|
June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
Kenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Lancet (London, England)
|
April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
American Heart Journal
|
September 11, 2013
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial
Emmanouil S Brilakis, Claes Held, Bernhard Meier, et al.
ESC Heart Failure
|
July 9, 2025
Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification
Veraprapas Kittipibul, Harriette G C Van Spall, William Schuyler Jones, et al.
Page
of 23
Search research articles
Search
Showing results (111-120 of 227) with videos related to
Sort By:
Page
of 23
Journal of the American Heart Association
|
July 24, 2018
Effects of Lipid-Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE-3 Trial
Gilles R Dagenais, Hyejung Jung, Eva Lonn, et al.
Journal of the American College of Cardiology
|
March 25, 2014
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes
Elaine M Hylek, Claes Held, John H Alexander, et al.
European Heart Journal
|
February 28, 2016
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
Ziad Hijazi, Johan Lindbäck, John H Alexander, et al.
Journal of the American Heart Association
|
October 26, 2017
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial
Claes Held, Harvey D White, Ralph A H Stewart, et al.
American Heart Journal
|
April 30, 2017
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome
Neha J Pagidipati, Connie N Hess, Robert M Clare, et al.
Journal of the American Heart Association
|
February 9, 2018
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
Tymon Pol, Claes Held, Johan Westerbergh, et al.
Circulation
|
June 29, 2011
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial
Kenneth W Mahaffey, Daniel M Wojdyla, Kevin Carroll, et al.
Lancet (London, England)
|
April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
American Heart Journal
|
September 11, 2013
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial
Emmanouil S Brilakis, Claes Held, Bernhard Meier, et al.
ESC Heart Failure
|
July 9, 2025
Clinical endpoints in pragmatic heart failure trials: From data collection to clinical endpoint classification
Veraprapas Kittipibul, Harriette G C Van Spall, William Schuyler Jones, et al.
Page
of 23